Related Experiment Video
Updated: Sep 16, 2025

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients
Published on: September 20, 2020
Cerebral Venous Sinus Thrombosis During Raloxifene Therapy: A Case Report
Shunsuke Kimura1, Tadataka Mizoguchi1, Yusuke Imamura1
1Cerebrovascular Medicine and Neurology, National Hospital Organization Kyushu Medical Center, Fukuoka, JPN.
None:
A 79-year-old woman taking raloxifene for osteoporosis was admitted to our hospital with right-sided hemiplegia and seizures. Computed tomography (CT) of the head revealed a subcortical hemorrhage in the left frontal to parietal lobes. CT venography (CTV) showed a disruption of the superior sagittal sinus, leading to a diagnosis of cerebral venous sinus thrombosis (CVST). In the absence of other thrombogenic factors, raloxifene was considered a potential contributing factor. She received continuous intravenous heparin followed by warfarin, without clinical deterioration, and was later transferred to a rehabilitation hospital. Although venous thrombosis is a recognized adverse effect of raloxifene, CVST remains an uncommon manifestation. We therefore present this case to highlight the potential association.
Related Concept Videos
Venous Thrombosis I: Introduction
Venous Thrombosis IV: Nursing Management
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...

